US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bioxcel Therapeutics Inc.

1.43

0.0000

Post-market: 1.430.0001+0.01%19:55 EDT

Volume:462.52K

Turnover:665.44K

Market Cap:34.82M

PE:-0.15

High:1.49

Open:1.45

Low:1.40

Close:1.43

52wk High:8.08

52wk Low:1.17

Shares:24.35M

Float Shares:22.09M

Volume Ratio:0.80

T/O Rate:2.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.2900

EPS(LYR):-23.5105

ROE:-1766.94%

ROA:-67.31%

PB:-0.39

PE(LYR):-0.06

Loading ...

Overview Company News Filings

BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Igalmi® Label Expansion in the at-Home Setting

THOMSON REUTERS

BioXcel Therapeutics Inc: Submission Timeline Supports Potential Approval of Igalmi Label Expansion as Early as Year-End 2026

THOMSON REUTERS

BioXcel Therapeutics Appoints Mark Pavao as Interim Chief Commercial Officer

BioXcel Therapeutics Inc - to Submit Snda This Month for Igalmi at-Home Use - SEC Filing

THOMSON REUTERS

BioXcel Therapeutics Plans sNDA Submission for IGALMI At-Home Use

BioXcel Therapeutics Plans sNDA Submission Seeking FDA Approval for At-Home Use of IGALMI

BioXcel Therapeutics Planning to Submit Snda This Month Seeking FDA Approval for at-Home Use of Igalmi®

THOMSON REUTERS

BioXcel Therapeutics Inc. held annual shareholder meeting

Analysts Conflicted on These Healthcare Names: Bioxcel Therapeutics (BTAI) and Day One Biopharmaceuticals (DAWN)

BioXcel Therapeutics Q3 revenue misses analyst expectations

BRIEF-BioXcel Therapeutics Q3 Basic EPS USD -2.18 Vs. IBES Estimate USD -1.24

BioXcel Therapeutics Q3 Basic EPS USD -2.18 VS. Ibes Estimate USD -1.24

THOMSON REUTERS

BioXcel Therapeutics Q3 Revenue USD 98 Thousand VS. Ibes Estimate USD 216 Thousand

THOMSON REUTERS

BioXcel Therapeutics Reports Phase 3 Study Results on BXCL501 for Agitation in Bipolar Disorder and Schizophrenia at Home

BioXcel Therapeutics Inc. Announces Date for 2025 Annual Stockholder Meeting

BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing

BioXcel Therapeutics Inc - Updates on Snda Submission for Igalmi Label Expansion - SEC Filing

THOMSON REUTERS

BioXcel Therapeutics Reports Positive Phase 3 Results for IGALMI At-Home Use

H.C. Wainwright Keeps Their Buy Rating on Bioxcel Therapeutics (BTAI)

BioXcel Therapeutics Announces Positive Correlation Study Results Supporting At-Home Use of BXCL501 for Acute Agitation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BTAI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BTAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BTAI\",,,,,undefined,":{"symbol":"BTAI","market":"US","secType":"STK","nameCN":"Bioxcel Therapeutics Inc.","latestPrice":1.43,"timestamp":1774468800000,"preClose":1.43,"halted":0,"volume":462521,"hourTrading":{"tag":"盘后","latestPrice":1.4301,"preClose":1.43,"latestTime":"19:55 EDT","volume":6809,"amount":9848.2767,"timestamp":1774482922315,"change":0.0001,"changeRate":0.00007,"amplitude":0.027762},"delay":0,"changeRate":0,"floatShares":22094200,"shares":24349785,"eps":-9.29,"marketStatus":"Not Yet Opened","change":0,"latestTime":"03-25 16:00:00 EDT","open":1.45,"high":1.49,"low":1.4,"amount":665441.9595401001,"amplitude":0.062937,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.29,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774512000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1520485200000,"exchange":"NASDAQ","adjPreClose":1.43,"preHourTrading":{"tag":"盘前","latestPrice":1.4516,"preClose":1.43,"latestTime":"09:29 EDT","volume":3612,"amount":5248.9154172,"timestamp":1774445398253,"change":0.0216,"changeRate":0.015105,"amplitude":0.020979},"postHourTrading":{"tag":"盘后","latestPrice":1.4301,"preClose":1.43,"latestTime":"19:55 EDT","volume":6809,"amount":9848.2767,"timestamp":1774482922315,"change":0.0001,"changeRate":0.00007,"amplitude":0.027762},"volumeRatio":0.801738,"impliedVol":0.2625,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BTAI\",,,,,undefined,":{"symbol":"BTAI","floatShares":22094200,"roa":"-67.31%","roe":"-1766.94%","lyrEps":-23.510453,"volumeRatio":0.801738,"shares":24349785,"dividePrice":0,"high":1.49,"amplitude":0.062937,"preClose":1.43,"low":1.4,"week52Low":1.17,"pbRate":"-0.39","psRate":"46.30","week52High":8.08,"institutionHeld":0,"latestPrice":1.43,"eps":-9.29,"divideRate":0,"volume":462521,"delay":0,"ttmEps":-9.29,"open":1.45,"prevYearClose":1.6,"prevWeekClose":1.51,"prevMonthClose":1.67,"prevQuarterClose":1.6,"fiveDayClose":1.65,"twentyDayClose":1.66,"sixtyDayClose":1.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BTAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"BTAI","fiscalQuarterEnding":"2025/09","expectedEps":-1.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-2.18},{"market":"US","date":"2025-08-12","symbol":"BTAI","fiscalQuarterEnding":"2025/06","expectedEps":-2.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-2.45},{"market":"US","date":"2025-05-12","symbol":"BTAI","fiscalQuarterEnding":"2025/03","expectedEps":-2.72,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.5},{"market":"US","date":"2025-03-27","symbol":"BTAI","fiscalQuarterEnding":"2024/12","expectedEps":-4.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-3.57},{"market":"US","date":"2025-02-10","symbol":"BTAI","defaultRemindTime":1739197800000,"type":"split","dateTimestamp":1739163600000,"forFactor":16,"toFactor":1,"ratio":16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BTAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BTAI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.8,"hold":0,"sell":0.2,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1753761600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BTAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BTAI","date":"2026-03-24","current":-0.153929,"percent":0.631325,"low":-12.907167,"twenty":-5.387729,"median":-1.037701,"eighty":-0.297799,"high":-0.075584,"avg":-2.772603,"sd":3.012184,"marketCap":35794183},"quantilePoints":[{"date":"2021-03-26","current":-12.425691,"twenty":-20.789027,"median":-12.600244,"eighty":-6.320225,"marketCap":1021006571},{"date":"2021-04-01","current":-11.253399,"twenty":-20.758838,"median":-12.561953,"eighty":-6.331584,"marketCap":924680560},{"date":"2021-04-09","current":-10.727064,"twenty":-20.728649,"median":-12.432604,"eighty":-6.378241,"marketCap":881432146},{"date":"2021-04-16","current":-10.476864,"twenty":-20.687139,"median":-12.317081,"eighty":-6.437827,"marketCap":860873476},{"date":"2021-04-23","current":-10.341969,"twenty":-20.622913,"median":-12.292905,"eighty":-6.451056,"marketCap":849789268},{"date":"2021-04-30","current":-10.183093,"twenty":-20.583252,"median":-12.183066,"eighty":-6.459911,"marketCap":836734534},{"date":"2021-05-07","current":-9.148896,"twenty":-20.554865,"median":-12.032854,"eighty":-6.509856,"marketCap":751755607},{"date":"2021-05-14","current":-8.27871,"twenty":-20.518918,"median":-12.003696,"eighty":-6.620208,"marketCap":775168693},{"date":"2021-05-21","current":-8.418135,"twenty":-20.453173,"median":-11.850922,"eighty":-6.772889,"marketCap":788223648},{"date":"2021-05-28","current":-8.689094,"twenty":-20.396568,"median":-11.727247,"eighty":-6.913691,"marketCap":813594596},{"date":"2021-06-04","current":-9.196812,"twenty":-20.389363,"median":-11.675065,"eighty":-6.970815,"marketCap":861134335},{"date":"2021-06-11","current":-9.959706,"twenty":-20.3602,"median":-11.515521,"eighty":-7.018081,"marketCap":932567103},{"date":"2021-06-18","current":-9.941291,"twenty":-20.355379,"median":-11.354209,"eighty":-7.04643,"marketCap":930842864},{"date":"2021-06-25","current":-9.223355,"twenty":-20.3371,"median":-11.302252,"eighty":-7.107214,"marketCap":863619618},{"date":"2021-07-02","current":-8.300426,"twenty":-20.317699,"median":-11.253399,"eighty":-7.191924,"marketCap":777202082},{"date":"2021-07-09","current":-8.297458,"twenty":-20.311661,"median":-11.233521,"eighty":-7.214514,"marketCap":776924212},{"date":"2021-07-16","current":-8.068952,"twenty":-20.302227,"median":-11.181625,"eighty":-7.285106,"marketCap":755528230},{"date":"2021-07-23","current":-7.377497,"twenty":-20.302227,"median":-11.0725,"eighty":-7.299225,"marketCap":690784546},{"date":"2021-07-30","current":-7.594133,"twenty":-20.289983,"median":-11.050676,"eighty":-7.299225,"marketCap":711069048},{"date":"2021-08-06","current":-7.775158,"twenty":-20.275433,"median":-11.028851,"eighty":-7.30854,"marketCap":728019111},{"date":"2021-08-13","current":-6.88901,"twenty":-20.226754,"median":-10.9362,"eighty":-7.214514,"marketCap":687757414},{"date":"2021-08-20","current":-6.79936,"twenty":-20.21378,"median":-10.839701,"eighty":-7.152356,"marketCap":678807338},{"date":"2021-08-27","current":-7.875155,"twenty":-20.198311,"median":-10.779276,"eighty":-7.152356,"marketCap":786208252},{"date":"2021-09-03","current":-8.174921,"twenty":-20.177467,"median":-10.727064,"eighty":-7.186277,"marketCap":816135069},{"date":"2021-09-10","current":-8.247761,"twenty":-20.160791,"median":-10.592353,"eighty":-7.189685,"marketCap":823407006},{"date":"2021-09-17","current":-8.600757,"twenty":-20.139947,"median":-10.523516,"eighty":-7.209299,"marketCap":858647931},{"date":"2021-09-24","current":-8.595153,"twenty":-20.132443,"median":-10.491853,"eighty":-7.214409,"marketCap":858088551},{"date":"2021-10-01","current":-8.603558,"twenty":-20.064907,"median":-10.476864,"eighty":-7.243231,"marketCap":858927621},{"date":"2021-10-08","current":-8.56994,"twenty":-20.044896,"median":-10.416911,"eighty":-7.278167,"marketCap":855571342},{"date":"2021-10-15","current":-7.589397,"twenty":-20.024372,"median":-10.358075,"eighty":-7.296401,"marketCap":757679884},{"date":"2021-10-22","current":-8.387839,"twenty":-20.019128,"median":-10.308995,"eighty":-7.306677,"marketCap":837391500},{"date":"2021-10-29","current":-8.163715,"twenty":-19.92803,"median":-10.209478,"eighty":-7.312382,"marketCap":815016310},{"date":"2021-11-05","current":-9.592505,"twenty":-19.890755,"median":-10.183093,"eighty":-7.358522,"marketCap":957658149},{"date":"2021-11-12","current":-9.48221,"twenty":-19.887125,"median":-10.075455,"eighty":-7.375417,"marketCap":966161312},{"date":"2021-11-19","current":-6.980532,"twenty":-19.884335,"median":-9.966705,"eighty":-7.312382,"marketCap":711260369},{"date":"2021-11-26","current":-6.200646,"twenty":-19.870263,"median":-9.949183,"eighty":-7.281907,"marketCap":631796190},{"date":"2021-12-03","current":-5.893085,"twenty":-19.857352,"median":-9.934768,"eighty":-7.204609,"marketCap":600458203},{"date":"2021-12-10","current":-6.000182,"twenty":-19.848143,"median":-9.906547,"eighty":-7.097817,"marketCap":611370538},{"date":"2021-12-17","current":-6.123755,"twenty":-19.833879,"median":-9.872898,"eighty":-6.982771,"marketCap":623961693},{"date":"2021-12-23","current":-6.250075,"twenty":-19.742233,"median":-9.857792,"eighty":-6.885243,"marketCap":636832652},{"date":"2021-12-31","current":-5.582778,"twenty":-19.598097,"median":-9.844099,"eighty":-6.774146,"marketCap":568840413},{"date":"2022-01-07","current":-5.412521,"twenty":-19.555399,"median":-9.824143,"eighty":-6.667102,"marketCap":551492599},{"date":"2022-01-14","current":-5.354853,"twenty":-19.528629,"median":-9.781651,"eighty":-6.538413,"marketCap":545616727},{"date":"2022-01-21","current":-4.580459,"twenty":-19.525826,"median":-9.694009,"eighty":-6.450701,"marketCap":466712154},{"date":"2022-01-28","current":-4.281137,"twenty":-19.506094,"median":-9.619374,"eighty":-6.317198,"marketCap":436213578},{"date":"2022-02-04","current":-4.300359,"twenty":-19.470536,"median":-9.561688,"eighty":-6.269377,"marketCap":438172202},{"date":"2022-02-11","current":-4.866051,"twenty":-19.46269,"median":-9.506227,"eighty":-6.227372,"marketCap":495811713},{"date":"2022-02-18","current":-4.618904,"twenty":-19.449928,"median":-9.48221,"eighty":-6.124854,"marketCap":470629402},{"date":"2022-02-25","current":-4.962164,"twenty":-19.429196,"median":-9.463733,"eighty":-6.107279,"marketCap":505604834},{"date":"2022-03-04","current":-4.555745,"twenty":-19.415697,"median":-9.395125,"eighty":-6.073524,"marketCap":464193923},{"date":"2022-03-11","current":-4.532077,"twenty":-19.396551,"median":-9.349077,"eighty":-6.038627,"marketCap":484619575},{"date":"2022-03-18","current":-4.621044,"twenty":-19.393714,"median":-9.299246,"eighty":-5.997436,"marketCap":494132892},{"date":"2022-03-25","current":-5.746214,"twenty":-19.377038,"median":-9.253759,"eighty":-5.966837,"marketCap":614448376},{"date":"2022-04-01","current":-5.63893,"twenty":-19.376494,"median":-9.223623,"eighty":-5.919017,"marketCap":602976434},{"date":"2022-04-08","current":-4.477127,"twenty":-19.344873,"median":-9.196812,"eighty":-5.881824,"marketCap":478743702},{"date":"2022-04-14","current":-4.076776,"twenty":-19.325837,"median":-9.148896,"eighty":-5.843734,"marketCap":435933775},{"date":"2022-04-22","current":-3.579609,"twenty":-19.309196,"median":-9.119073,"eighty":-5.77521,"marketCap":382771119},{"date":"2022-04-29","current":-3.430458,"twenty":-19.297794,"median":-9.093709,"eighty":-5.740416,"marketCap":366822322},{"date":"2022-05-06","current":-3.286541,"twenty":-19.293358,"median":-9.077475,"eighty":-5.708502,"marketCap":351433133},{"date":"2022-05-13","current":-2.932736,"twenty":-19.289482,"median":-9.043401,"eighty":-5.671836,"marketCap":328545602},{"date":"2022-05-20","current":-3.389883,"twenty":-19.27932,"median":-9.010461,"eighty":-5.635438,"marketCap":379758417},{"date":"2022-05-27","current":-3.060138,"twenty":-19.235731,"median":-9.000731,"eighty":-5.584169,"marketCap":342818026},{"date":"2022-06-03","current":-2.790346,"twenty":-19.214888,"median":-8.893818,"eighty":-5.547086,"marketCap":312594069},{"date":"2022-06-10","current":-2.563021,"twenty":-19.151264,"median":-8.868016,"eighty":-5.529706,"marketCap":287127587},{"date":"2022-06-17","current":-2.580508,"twenty":-19.111096,"median":-8.841332,"eighty":-5.458772,"marketCap":289086547},{"date":"2022-06-24","current":-3.025165,"twenty":-19.10053,"median":-8.830484,"eighty":-5.439433,"marketCap":338900105},{"date":"2022-07-01","current":-3.564748,"twenty":-19.080598,"median":-8.812395,"eighty":-5.402564,"marketCap":399348019},{"date":"2022-07-08","current":-4.049374,"twenty":-19.067868,"median":-8.774902,"eighty":-5.364662,"marketCap":453639200},{"date":"2022-07-15","current":-4.20925,"twenty":-19.054365,"median":-8.739355,"eighty":-5.335491,"marketCap":471549693},{"date":"2022-07-22","current":-3.959443,"twenty":-19.045767,"median":-8.692552,"eighty":-5.283453,"marketCap":443564548},{"date":"2022-07-29","current":-3.857022,"twenty":-19.036648,"median":-8.681202,"eighty":-5.201946,"marketCap":432090638},{"date":"2022-08-05","current":-4.099335,"twenty":-19.026333,"median":-8.636548,"eighty":-5.1768,"marketCap":459236229},{"date":"2022-08-12","current":-3.590093,"twenty":-19.001261,"median":-8.623896,"eighty":-5.101853,"marketCap":438271352},{"date":"2022-08-19","current":-3.314638,"twenty":-18.973288,"median":-8.609161,"eighty":-5.040968,"marketCap":404644394},{"date":"2022-08-26","current":-3.153956,"twenty":-18.960428,"median":-8.595153,"eighty":-5.026382,"marketCap":385028669},{"date":"2022-09-02","current":-3.229706,"twenty":-18.95028,"median":-8.584677,"eighty":-4.986434,"marketCap":394276082},{"date":"2022-09-09","current":-3.351365,"twenty":-18.944157,"median":-8.576943,"eighty":-4.953378,"marketCap":409127989},{"date":"2022-09-16","current":-2.885388,"twenty":-18.933804,"median":-8.565041,"eighty":-4.932428,"marketCap":352242385},{"date":"2022-09-23","current":-2.648956,"twenty":-18.93029,"median":-8.528219,"eighty":-4.904497,"marketCap":323379246},{"date":"2022-09-30","current":-2.713229,"twenty":-18.898026,"median":-8.505504,"eighty":-4.846829,"marketCap":331225536},{"date":"2022-10-07","current":-2.547956,"twenty":-18.860022,"median":-8.495466,"eighty":-4.830352,"marketCap":311049361},{"date":"2022-10-14","current":-2.352842,"twenty":-18.849372,"median":-8.490353,"eighty":-4.786415,"marketCap":287230266},{"date":"2022-10-21","current":-2.476797,"twenty":-18.835428,"median":-8.461538,"eighty":-4.723255,"marketCap":302362397},{"date":"2022-10-28","current":-2.899161,"twenty":-18.798724,"median":-8.422299,"eighty":-4.643871,"marketCap":353923732},{"date":"2022-11-04","current":-2.690274,"twenty":-18.779213,"median":-8.416994,"eighty":-4.629889,"marketCap":328423289},{"date":"2022-11-11","current":-3.236176,"twenty":-18.760041,"median":-8.409862,"eighty":-4.59408,"marketCap":443595620},{"date":"2022-11-18","current":-3.105423,"twenty":-18.747535,"median":-8.380835,"eighty":-4.555745,"marketCap":425672787},{"date":"2022-11-25","current":-3.191287,"twenty":-18.737529,"median":-8.351893,"eighty":-4.504871,"marketCap":437442542},{"date":"2022-12-02","current":-3.706473,"twenty":-18.675558,"median":-8.341003,"eighty":-4.415505,"marketCap":508061069},{"date":"2022-12-09","current":-3.479546,"twenty":-18.6305,"median":-8.331654,"eighty":-4.345395,"marketCap":476955289},{"date":"2022-12-16","current":-4.098995,"twenty":-18.605889,"median":-8.323403,"eighty":-4.271217,"marketCap":561865661},{"date":"2022-12-23","current":-4.491517,"twenty":-18.56943,"median":-8.314138,"eighty":-4.267409,"marketCap":615670253},{"date":"2022-12-30","current":-4.391342,"twenty":-18.553041,"median":-8.299706,"eighty":-4.270731,"marketCap":601938873},{"date":"2023-01-06","current":-4.601914,"twenty":-18.536176,"median":-8.295853,"eighty":-4.275476,"marketCap":630802794},{"date":"2023-01-13","current":-5.916455,"twenty":-18.512161,"median":-8.284096,"eighty":-4.288826,"marketCap":810992131},{"date":"2023-01-20","current":-6.194491,"twenty":-18.499431,"median":-8.28262,"eighty":-4.303427,"marketCap":849103717},{"date":"2023-01-27","current":-6.472528,"twenty":-18.490876,"median":-8.269143,"eighty":-4.315927,"marketCap":887215303},{"date":"2023-02-03","current":-6.210847,"twenty":-18.489518,"median":-8.247761,"eighty":-4.322333,"marketCap":851345575},{"date":"2023-02-10","current":-6.773053,"twenty":-18.479167,"median":-8.233107,"eighty":-4.345549,"marketCap":928409444},{"date":"2023-02-17","current":-6.611546,"twenty":-18.458736,"median":-8.176114,"eighty":-4.350871,"marketCap":906271096},{"date":"2023-02-24","current":-6.037074,"twenty":-18.455712,"median":-8.174921,"eighty":-4.352535,"marketCap":827525834},{"date":"2023-03-03","current":-6.182225,"twenty":-18.445012,"median":-8.167369,"eighty":-4.364131,"marketCap":847422324},{"date":"2023-03-10","current":-3.492823,"twenty":-18.237642,"median":-8.147964,"eighty":-4.351703,"marketCap":578959828},{"date":"2023-03-17","current":-3.398741,"twenty":-18.047626,"median":-8.068952,"eighty":-4.29267,"marketCap":563365189},{"date":"2023-03-24","current":-3.206228,"twenty":-17.95461,"median":-8.038882,"eighty":-4.227497,"marketCap":531454699},{"date":"2023-03-31","current":-3.265732,"twenty":-17.876582,"median":-8.003763,"eighty":-4.208799,"marketCap":541317941},{"date":"2023-04-06","current":-2.985712,"twenty":-17.781403,"median":-7.981738,"eighty":-4.159863,"marketCap":494902684},{"date":"2023-04-14","current":-3.349738,"twenty":-17.69101,"median":-7.932562,"eighty":-4.119975,"marketCap":555242519},{"date":"2023-04-21","current":-3.701513,"twenty":-17.526694,"median":-7.875736,"eighty":-4.092862,"marketCap":613551686},{"date":"2023-04-28","current":-3.607006,"twenty":-17.370102,"median":-7.82875,"eighty":-4.073925,"marketCap":597886536},{"date":"2023-05-05","current":-3.971032,"twenty":-17.228301,"median":-7.773544,"eighty":-4.019732,"marketCap":658226371},{"date":"2023-05-12","current":-4.197584,"twenty":-17.132362,"median":-7.765133,"eighty":-4.019732,"marketCap":785288139},{"date":"2023-05-19","current":-4.135135,"twenty":-17.038021,"median":-7.736896,"eighty":-4.019732,"marketCap":773605196},{"date":"2023-05-26","current":-3.011338,"twenty":-16.914292,"median":-7.72182,"eighty":-4.00749,"marketCap":563364206},{"date":"2023-06-02","current":-2.828975,"twenty":-16.784295,"median":-7.712188,"eighty":-3.968298,"marketCap":529247429},{"date":"2023-06-09","current":-3.179674,"twenty":-16.58895,"median":-7.69454,"eighty":-3.946453,"marketCap":594856615},{"date":"2023-06-16","current":-3.351127,"twenty":-16.373858,"median":-7.687481,"eighty":-3.90696,"marketCap":626932217},{"date":"2023-06-23","current":-2.959903,"twenty":-16.274147,"median":-7.666303,"eighty":-3.878276,"marketCap":553741525},{"date":"2023-06-30","current":-0.995986,"twenty":-16.233994,"median":-7.631008,"eighty":-3.856568,"marketCap":186330086},{"date":"2023-07-07","current":-1.695826,"twenty":-15.980425,"median":-7.602771,"eighty":-3.818644,"marketCap":317256861},{"date":"2023-07-14","current":-1.775318,"twenty":-15.670542,"median":-7.591826,"eighty":-3.783112,"marketCap":332128276},{"date":"2023-07-21","current":-1.750379,"twenty":-15.533519,"median":-7.567475,"eighty":-3.753808,"marketCap":327462734},{"date":"2023-07-28","current":-1.482289,"twenty":-14.995263,"median":-7.547374,"eighty":-3.704487,"marketCap":277308157},{"date":"2023-08-04","current":-1.203288,"twenty":-14.584599,"median":-7.482764,"eighty":-3.674961,"marketCap":225112405},{"date":"2023-08-11","current":-1.151853,"twenty":-14.413652,"median":-7.440409,"eighty":-3.656953,"marketCap":215489724},{"date":"2023-08-18","current":-0.63171,"twenty":-14.413652,"median":-7.405113,"eighty":-3.629458,"marketCap":128190322},{"date":"2023-08-25","current":-0.56176,"twenty":-14.451968,"median":-7.373317,"eighty":-3.604961,"marketCap":113995732},{"date":"2023-09-01","current":-0.545174,"twenty":-14.451968,"median":-7.281108,"eighty":-3.573665,"marketCap":110630004},{"date":"2023-09-08","current":-0.493253,"twenty":-14.355672,"median":-7.202263,"eighty":-3.535658,"marketCap":100093813},{"date":"2023-09-15","current":-0.491811,"twenty":-14.355672,"median":-7.061812,"eighty":-3.506216,"marketCap":99801141},{"date":"2023-09-22","current":-0.435562,"twenty":-14.355672,"median":-6.92457,"eighty":-3.479923,"marketCap":88386934},{"date":"2023-09-29","current":-0.359123,"twenty":-14.355672,"median":-6.797451,"eighty":-3.444632,"marketCap":72875320},{"date":"2023-10-06","current":-0.379314,"twenty":-14.426087,"median":-6.695703,"eighty":-3.431215,"marketCap":76972728},{"date":"2023-10-13","current":-0.432678,"twenty":-14.426087,"median":-6.659241,"eighty":-3.406518,"marketCap":87801591},{"date":"2023-10-20","current":-0.373545,"twenty":-14.426087,"median":-6.56724,"eighty":-3.381455,"marketCap":75802040},{"date":"2023-10-27","current":-0.432678,"twenty":-14.567515,"median":-6.538502,"eighty":-3.35895,"marketCap":87801591},{"date":"2023-11-03","current":-0.575462,"twenty":-14.567515,"median":-6.472064,"eighty":-3.341914,"marketCap":116776116},{"date":"2023-11-10","current":-0.682189,"twenty":-14.567515,"median":-6.396828,"eighty":-3.320055,"marketCap":138433841},{"date":"2023-11-17","current":-0.58793,"twenty":-14.567515,"median":-6.396828,"eighty":-3.314434,"marketCap":124408851},{"date":"2023-11-24","current":-0.543662,"twenty":-14.567515,"median":-6.396828,"eighty":-3.296256,"marketCap":115041597},{"date":"2023-12-01","current":-0.525678,"twenty":-14.567515,"median":-6.396828,"eighty":-3.27845,"marketCap":111236149},{"date":"2023-12-08","current":-0.484177,"twenty":-14.566917,"median":-6.364176,"eighty":-3.262841,"marketCap":102454348},{"date":"2023-12-15","current":-0.44821,"twenty":-14.566917,"median":-6.364176,"eighty":-3.225115,"marketCap":94843454},{"date":"2023-12-22","current":-0.410859,"twenty":-14.566917,"median":-6.364176,"eighty":-3.207524,"marketCap":86939832},{"date":"2023-12-29","current":-0.415009,"twenty":-14.567515,"median":-6.396828,"eighty":-3.205905,"marketCap":87818013},{"date":"2024-01-05","current":-0.387342,"twenty":-14.568113,"median":-6.42948,"eighty":-3.192901,"marketCap":81963478},{"date":"2024-01-12","current":-0.370742,"twenty":-14.568113,"median":-6.327377,"eighty":-3.160117,"marketCap":78450758},{"date":"2024-01-19","current":-0.359265,"twenty":-14.568711,"median":-6.330444,"eighty":-3.138953,"marketCap":76022192},{"date":"2024-01-26","current":-0.465347,"twenty":-14.568113,"median":-6.327377,"eighty":-3.125722,"marketCap":98469690},{"date":"2024-02-02","current":-0.449788,"twenty":-14.568113,"median":-6.327377,"eighty":-3.097458,"marketCap":95177390},{"date":"2024-02-09","current":-0.538419,"twenty":-14.568113,"median":-6.286489,"eighty":-3.03805,"marketCap":113932140},{"date":"2024-02-16","current":-0.515446,"twenty":-14.568113,"median":-6.239468,"eighty":-3.02044,"marketCap":109071035},{"date":"2024-02-23","current":-0.455143,"twenty":-14.568113,"median":-6.1979,"eighty":-3.008421,"marketCap":96310635},{"date":"2024-03-01","current":-0.456579,"twenty":-14.567515,"median":-6.149515,"eighty":-2.982732,"marketCap":96614454},{"date":"2024-03-08","current":-0.436478,"twenty":-14.567515,"median":-6.093549,"eighty":-2.940264,"marketCap":92360988},{"date":"2024-03-15","current":-0.486985,"twenty":-14.567515,"median":-6.03785,"eighty":-2.923516,"marketCap":87196064},{"date":"2024-03-22","current":-0.480197,"twenty":-14.567515,"median":-5.998481,"eighty":-2.897325,"marketCap":85980788},{"date":"2024-03-28","current":-0.491814,"twenty":-14.567515,"median":-5.951356,"eighty":-2.876482,"marketCap":88060812},{"date":"2024-04-05","current":-0.459368,"twenty":-14.568113,"median":-5.86837,"eighty":-2.834275,"marketCap":82251244},{"date":"2024-04-12","current":-0.476445,"twenty":-14.568113,"median":-5.822413,"eighty":-2.809293,"marketCap":85308912},{"date":"2024-04-19","current":-0.527431,"twenty":-14.568113,"median":-5.753035,"eighty":-2.797201,"marketCap":94438018},{"date":"2024-04-26","current":-0.539841,"twenty":-14.567515,"median":-5.715607,"eighty":-2.765565,"marketCap":96660089},{"date":"2024-05-03","current":-0.529499,"twenty":-14.567515,"median":-5.666243,"eighty":-2.740784,"marketCap":94808363},{"date":"2024-05-10","current":-0.565238,"twenty":-14.567515,"median":-5.584105,"eighty":-2.701389,"marketCap":86508542},{"date":"2024-05-17","current":-0.512515,"twenty":-14.567515,"median":-5.52894,"eighty":-2.689815,"marketCap":78439415},{"date":"2024-05-24","current":-0.453662,"twenty":-14.567515,"median":-5.452123,"eighty":-2.677462,"marketCap":69432018},{"date":"2024-05-31","current":-0.443853,"twenty":-14.567515,"median":-5.400125,"eighty":-2.647745,"marketCap":67930776},{"date":"2024-06-07","current":-0.34699,"twenty":-14.567515,"median":-5.330699,"eighty":-2.582012,"marketCap":53106104},{"date":"2024-06-14","current":-0.335955,"twenty":-14.567515,"median":-5.201946,"eighty":-2.519951,"marketCap":51417217},{"date":"2024-06-21","current":-0.279554,"twenty":-14.568113,"median":-5.174164,"eighty":-2.476165,"marketCap":42785130},{"date":"2024-06-28","current":-0.313885,"twenty":-14.568113,"median":-5.054629,"eighty":-2.408393,"marketCap":48039444},{"date":"2024-07-05","current":-0.257484,"twenty":-14.568113,"median":-5.022578,"eighty":-2.303222,"marketCap":39407356},{"date":"2024-07-12","current":-0.296719,"twenty":-14.568113,"median":-4.962164,"eighty":-1.768148,"marketCap":45412287},{"date":"2024-07-19","current":-0.28691,"twenty":-14.568113,"median":-4.922049,"eighty":-1.702373,"marketCap":43911054},{"date":"2024-07-26","current":-0.282006,"twenty":-14.568113,"median":-4.866051,"eighty":-1.600436,"marketCap":43160438},{"date":"2024-08-02","current":-0.24277,"twenty":-14.568113,"median":-4.830352,"eighty":-1.459221,"marketCap":37155507},{"date":"2024-08-09","current":-0.276242,"twenty":-14.568113,"median":-4.786415,"eighty":-1.190196,"marketCap":29787762},{"date":"2024-08-16","current":-0.254365,"twenty":-14.568113,"median":-4.723255,"eighty":-1.147489,"marketCap":27428699},{"date":"2024-08-23","current":-0.256557,"twenty":-14.568113,"median":-4.638127,"eighty":-0.72661,"marketCap":27665013},{"date":"2024-08-30","current":-0.232375,"twenty":-14.568113,"median":-4.601914,"eighty":-0.654786,"marketCap":25057412},{"date":"2024-09-06","current":-0.206454,"twenty":-14.568113,"median":-4.585559,"eighty":-0.620419,"marketCap":22262390},{"date":"2024-09-13","current":-0.256934,"twenty":-14.568113,"median":-4.546716,"eighty":-0.588861,"marketCap":27705756},{"date":"2024-09-20","current":-0.217865,"twenty":-14.568113,"median":-4.477127,"eighty":-0.577625,"marketCap":23492852},{"date":"2024-09-27","current":-0.227803,"twenty":-14.568113,"median":-4.409094,"eighty":-0.569335,"marketCap":24564412},{"date":"2024-10-04","current":-0.220964,"twenty":-14.568113,"median":-4.391342,"eighty":-0.561266,"marketCap":23826950},{"date":"2024-10-11","current":-0.198935,"twenty":-14.568113,"median":-4.391342,"eighty":-0.544695,"marketCap":21451589},{"date":"2024-10-18","current":-0.213785,"twenty":-14.568113,"median":-4.391342,"eighty":-0.539709,"marketCap":23052819},{"date":"2024-10-25","current":-0.230712,"twenty":-14.568113,"median":-4.391342,"eighty":-0.537202,"marketCap":24878139},{"date":"2024-11-01","current":-0.242992,"twenty":-14.568113,"median":-4.391342,"eighty":-0.530658,"marketCap":26202312},{"date":"2024-11-08","current":-0.256934,"twenty":-14.568113,"median":-4.391342,"eighty":-0.525552,"marketCap":27705756},{"date":"2024-11-15","current":-0.342187,"twenty":-14.568113,"median":-4.391342,"eighty":-0.517673,"marketCap":24293888},{"date":"2024-11-22","current":-0.306481,"twenty":-14.568113,"median":-4.391342,"eighty":-0.510553,"marketCap":21758911},{"date":"2024-11-29","current":-0.278325,"twenty":-14.568113,"median":-4.391342,"eighty":-0.504679,"marketCap":19759971},{"date":"2024-12-06","current":-0.277712,"twenty":-14.568113,"median":-4.391342,"eighty":-0.493111,"marketCap":19716457},{"date":"2024-12-13","current":-0.280641,"twenty":-14.568113,"median":-4.391342,"eighty":-0.488033,"marketCap":19924355},{"date":"2024-12-20","current":-0.238372,"twenty":-14.568113,"median":-4.350455,"eighty":-0.485697,"marketCap":16923469},{"date":"2024-12-27","current":-0.275281,"twenty":-14.568113,"median":-4.300359,"eighty":-0.482078,"marketCap":19543878},{"date":"2025-01-03","current":-0.289402,"twenty":-14.568113,"median":-4.259943,"eighty":-0.48105,"marketCap":20546382},{"date":"2025-01-10","current":-0.263747,"twenty":-14.568711,"median":-4.220236,"eighty":-0.476539,"marketCap":18725000},{"date":"2025-01-17","current":-0.240469,"twenty":-14.568711,"median":-4.192077,"eighty":-0.468706,"marketCap":17072356},{"date":"2025-01-24","current":-0.237673,"twenty":-14.568711,"median":-4.143465,"eighty":-0.46289,"marketCap":16873840},{"date":"2025-01-31","current":-0.227887,"twenty":-14.568711,"median":-4.099165,"eighty":-0.4563,"marketCap":16179035},{"date":"2025-02-07","current":-0.115341,"twenty":-14.568711,"median":-4.065907,"eighty":-0.454445,"marketCap":8188775},{"date":"2025-02-14","current":-0.100924,"twenty":-14.568711,"median":-4.028488,"eighty":-0.45083,"marketCap":7165178},{"date":"2025-02-21","current":-0.09306,"twenty":-14.00912,"median":-3.965237,"eighty":-0.449122,"marketCap":6606853},{"date":"2025-02-28","current":-0.09437,"twenty":-13.519531,"median":-3.93583,"eighty":-0.446242,"marketCap":6699907},{"date":"2025-03-07","current":-0.161105,"twenty":-12.701756,"median":-3.878276,"eighty":-0.441493,"marketCap":11437790},{"date":"2025-03-14","current":-0.101826,"twenty":-12.316075,"median":-3.829136,"eighty":-0.438526,"marketCap":7229226},{"date":"2025-03-21","current":-0.111387,"twenty":-12.316075,"median":-3.775982,"eighty":-0.435904,"marketCap":7908026},{"date":"2025-03-28","current":-0.195144,"twenty":-12.068958,"median":-3.724625,"eighty":-0.432705,"marketCap":11630400},{"date":"2025-04-04","current":-0.149548,"twenty":-11.215718,"median":-3.690118,"eighty":-0.420757,"marketCap":8912901},{"date":"2025-04-11","current":-0.166062,"twenty":-10.584929,"median":-3.670136,"eighty":-0.414659,"marketCap":9897148},{"date":"2025-04-17","current":-0.15964,"twenty":-10.476864,"median":-3.646134,"eighty":-0.407036,"marketCap":9514386},{"date":"2025-04-25","current":-0.171567,"twenty":-10.341969,"median":-3.607006,"eighty":-0.399713,"marketCap":10225231},{"date":"2025-05-02","current":-0.16331,"twenty":-10.199879,"median":-3.547261,"eighty":-0.391341,"marketCap":9733107},{"date":"2025-05-09","current":-0.140373,"twenty":-9.957601,"median":-3.482206,"eighty":-0.383469,"marketCap":8366098},{"date":"2025-05-16","current":-0.219192,"twenty":-9.848807,"median":-3.442342,"eighty":-0.372304,"marketCap":8781266},{"date":"2025-05-23","current":-0.207099,"twenty":-9.68296,"median":-3.413343,"eighty":-0.363045,"marketCap":8296783},{"date":"2025-05-30","current":-0.185935,"twenty":-9.516654,"median":-3.388241,"eighty":-0.359151,"marketCap":7448936},{"date":"2025-06-06","current":-0.231285,"twenty":-9.274753,"median":-3.351127,"eighty":-0.353372,"marketCap":9265750},{"date":"2025-06-13","current":-0.267565,"twenty":-9.160886,"median":-3.330706,"eighty":-0.347438,"marketCap":10719201},{"date":"2025-06-20","current":-0.261519,"twenty":-9.043401,"median":-3.316885,"eighty":-0.342187,"marketCap":10476959},{"date":"2025-06-27","current":-0.306869,"twenty":-8.862718,"median":-3.304091,"eighty":-0.326146,"marketCap":12293773},{"date":"2025-07-03","current":-0.291752,"twenty":-8.782857,"median":-3.283374,"eighty":-0.315848,"marketCap":11688168},{"date":"2025-07-11","current":-0.302334,"twenty":-8.631574,"median":-3.264787,"eighty":-0.309908,"marketCap":12112092},{"date":"2025-07-18","current":-0.293264,"twenty":-8.600757,"median":-3.227411,"eighty":-0.305357,"marketCap":11748729},{"date":"2025-07-25","current":-0.261519,"twenty":-8.56994,"median":-3.204084,"eighty":-0.301578,"marketCap":10476959},{"date":"2025-08-01","current":-0.198029,"twenty":-8.490353,"median":-3.174933,"eighty":-0.297799,"marketCap":7933420},{"date":"2025-08-08","current":-0.515479,"twenty":-8.387839,"median":-3.140446,"eighty":-0.297799,"marketCap":20651116},{"date":"2025-08-15","current":-1.357106,"twenty":-8.333954,"median":-3.124847,"eighty":-0.297799,"marketCap":69144529},{"date":"2025-08-22","current":-1.494245,"twenty":-8.297458,"median":-3.097392,"eighty":-0.297799,"marketCap":76131765},{"date":"2025-08-29","current":-1.171396,"twenty":-8.250563,"median":-3.03662,"eighty":-0.297799,"marketCap":59682646},{"date":"2025-09-05","current":-1.019972,"twenty":-8.175852,"median":-3.023808,"eighty":-0.297583,"marketCap":51967572},{"date":"2025-09-12","current":-0.968545,"twenty":-8.163715,"median":-3.008192,"eighty":-0.297799,"marketCap":49347358},{"date":"2025-09-19","current":-1.160684,"twenty":-8.04605,"median":-2.96111,"eighty":-0.297799,"marketCap":59136871},{"date":"2025-09-26","current":-1.087419,"twenty":-7.997228,"median":-2.930869,"eighty":-0.297799,"marketCap":55403978},{"date":"2025-10-03","current":-1.018009,"twenty":-7.894766,"median":-2.903752,"eighty":-0.297799,"marketCap":51867554},{"date":"2025-10-10","current":-1.071994,"twenty":-7.775158,"median":-2.869035,"eighty":-0.297799,"marketCap":54618106},{"date":"2025-10-17","current":-0.948599,"twenty":-7.698,"median":-2.820454,"eighty":-0.297799,"marketCap":48331130},{"date":"2025-10-24","current":-0.871477,"twenty":-7.564457,"median":-2.800397,"eighty":-0.297799,"marketCap":44401770},{"date":"2025-10-31","current":-0.778931,"twenty":-7.416076,"median":-2.764876,"eighty":-0.297799,"marketCap":39686538},{"date":"2025-11-07","current":-0.686385,"twenty":-7.190537,"median":-2.735777,"eighty":-0.297799,"marketCap":34971305},{"date":"2025-11-14","current":-0.687787,"twenty":-6.88901,"median":-2.695041,"eighty":-0.297799,"marketCap":35042741},{"date":"2025-11-21","current":-0.573901,"twenty":-6.773053,"median":-2.684508,"eighty":-0.297799,"marketCap":39146388},{"date":"2025-11-28","current":-0.721384,"twenty":-6.679011,"median":-2.643217,"eighty":-0.297799,"marketCap":49206354},{"date":"2025-12-05","current":-0.670086,"twenty":-6.648345,"median":-2.574561,"eighty":-0.297799,"marketCap":45707236},{"date":"2025-12-12","current":-0.663674,"twenty":-6.544082,"median":-2.508933,"eighty":-0.297799,"marketCap":45269846},{"date":"2025-12-19","current":-0.586726,"twenty":-6.472528,"median":-2.439329,"eighty":-0.297799,"marketCap":40021168},{"date":"2025-12-26","current":-0.548252,"twenty":-6.296758,"median":-2.364319,"eighty":-0.297799,"marketCap":37396829},{"date":"2026-01-02","current":-0.512984,"twenty":-6.250075,"median":-2.051388,"eighty":-0.297799,"marketCap":34991185},{"date":"2026-01-09","current":-0.641231,"twenty":-6.1979,"median":-1.74882,"eighty":-0.297799,"marketCap":43738982},{"date":"2026-01-16","current":-0.612375,"twenty":-6.137249,"median":-1.659198,"eighty":-0.297799,"marketCap":41770727},{"date":"2026-01-23","current":-0.580314,"twenty":-6.107279,"median":-1.60269,"eighty":-0.297799,"marketCap":39583778},{"date":"2026-01-30","current":-0.519397,"twenty":-6.037074,"median":-1.531386,"eighty":-0.297799,"marketCap":35428575},{"date":"2026-02-06","current":-0.439243,"twenty":-5.986452,"median":-1.457102,"eighty":-0.297799,"marketCap":29961202},{"date":"2026-02-13","current":-0.493748,"twenty":-5.86837,"median":-1.292666,"eighty":-0.297799,"marketCap":33679016},{"date":"2026-02-20","current":-0.519397,"twenty":-5.822413,"median":-1.21546,"eighty":-0.297799,"marketCap":35428575},{"date":"2026-02-27","current":-0.564283,"twenty":-5.753035,"median":-1.164841,"eighty":-0.297799,"marketCap":38490304},{"date":"2026-03-06","current":-0.516191,"twenty":-5.675564,"median":-1.152972,"eighty":-0.297799,"marketCap":35209880},{"date":"2026-03-13","current":-0.609676,"twenty":-5.541587,"median":-1.102843,"eighty":-0.297799,"marketCap":41586622},{"date":"2026-03-20","current":-0.571164,"twenty":-5.437236,"median":-1.067672,"eighty":-0.297799,"marketCap":38959656},{"date":"2026-03-24","current":-0.524757,"twenty":-5.387729,"median":-1.037701,"eighty":-0.297799,"marketCap":35794183}],"updateTime":1774498143329},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BTAI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604190365","title":"BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Igalmi® Label Expansion in the at-Home Setting","url":"https://stock-news.laohu8.com/highlight/detail?id=2604190365","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604190365?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:00","pubTimestamp":1768910402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA93YYSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2604190352","title":"BioXcel Therapeutics Inc: Submission Timeline Supports Potential Approval of Igalmi Label Expansion as Early as Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604190352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604190352?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:00","pubTimestamp":1768910402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA93YYSZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2603542869","title":"BioXcel Therapeutics Appoints Mark Pavao as Interim Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542869","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603542869?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:27","pubTimestamp":1768235267,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. has announced that Mark Pavao will join the company as Interim Chief Commercial Officer to support the potential launch of IGALMI for at-home use.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL40Fk6X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2602512882","title":"BioXcel Therapeutics Inc - to Submit Snda This Month for Igalmi at-Home Use - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512882?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:12","pubTimestamp":1768219978,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2602514938","title":"BioXcel Therapeutics Plans sNDA Submission for IGALMI At-Home Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2602514938","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602514938?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:01","pubTimestamp":1768219282,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. announced that it is on track to submit a supplemental New Drug Application  to the U.S. Food and Drug Administration  seeking approval for IGALMI for at-home use in the acute treatment of agitation associated with bipolar disorders or schizophrenia. The company expects to submit the sNDA this month, with the potential for FDA approval and an at-home launch of IGALMI as early as year-end 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8wvVvK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","BK4139","LU2210149790.SGD","SG9999014005.SGD","BK4588","BK4112","NDAQ","IE00BKPKM429.USD","BK4585","BTAI","SG9999014013.SGD"],"gpt_icon":0},{"id":"2601870313","title":"BioXcel Therapeutics Plans sNDA Submission Seeking FDA Approval for At-Home Use of IGALMI","url":"https://stock-news.laohu8.com/highlight/detail?id=2601870313","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601870313?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:01","pubTimestamp":1767787264,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. has announced plans to submit a supplemental New Drug Application  to the U.S. Food and Drug Administration  seeking approval for at-home use of IGALMI  sublingual film for the acute treatment of agitation associated with bipolar disorders or schizophrenia. If approved, IGALMI could become the first FDA-approved at-home treatment option for these conditions as early as 2026. The company is now focused on launch planning to address this unmet need for patients and caregivers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 07, 2026, and is solely responsible for the information contained therei","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL3C0JyH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BGHQF748.EUR","BTAI","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","BK4139","BK4588","NDAQ","SG9999014005.SGD","LU0314104364.USD","SG9999014039.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2601021877","title":"BioXcel Therapeutics Planning to Submit Snda This Month Seeking FDA Approval for at-Home Use of Igalmi®","url":"https://stock-news.laohu8.com/highlight/detail?id=2601021877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601021877?lang=en_us&edition=fundamental","pubTime":"2026-01-07 20:00","pubTimestamp":1767787203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUACTFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2591624400","title":"BioXcel Therapeutics Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2591624400","media":"Reuters","labels":["shareholding","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591624400?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:31","pubTimestamp":1765834268,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. held its annual meeting of stockholders on December 12, 2025. During the meeting, three nominees were elected to the board of directors. Stockholders approved the ratification of Ernst & Young LLP as the company's independent registered public accounting firm for the year ending December 31, 2025. An amendment authorizing a potential reverse stock split at a ratio to be determined by the board was also approved. In addition, authorization for possible adjournments of the annual meeting to solicit additional proxies was granted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analys","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL6Hxgrx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2583941485","title":"Analysts Conflicted on These Healthcare Names: Bioxcel Therapeutics (BTAI) and Day One Biopharmaceuticals (DAWN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583941485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583941485?lang=en_us&edition=fundamental","pubTime":"2025-11-13 23:30","pubTimestamp":1763047836,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bioxcel Therapeutics (BTAI – Research Report) and Day One Biophar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-bioxcel-therapeutics-btai-and-day-one-biopharmaceuticals-dawn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-bioxcel-therapeutics-btai-and-day-one-biopharmaceuticals-dawn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4137","BK4588","LU0128526141.USD","BK4539","XLV","BK4585","DAWN","XBI","LABU","LU0029874061.USD","BK4581","BTAI","BK4139"],"gpt_icon":0},{"id":"2582755553","title":"BioXcel Therapeutics Q3 revenue misses analyst expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2582755553","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582755553?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:09","pubTimestamp":1762949389,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Q3 revenue misses analyst expectationsOverviewBioXcel Q3 2025 revenue and net income miss analyst expectationsCompany plans sNDA submission for BXCL501 in Q1 2026BioXcel advances ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2582637396","title":"BRIEF-BioXcel Therapeutics Q3 Basic EPS USD -2.18 Vs. IBES Estimate USD -1.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2582637396","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582637396?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948847,"startTime":"0","endTime":"0","summary":"Nov 12  - BioXcel Therapeutics Q3 net income USD -30.911 million vs. IBES estimate USD -14.1 million.Q3 operating income USD -14.228 million vs. IBES estimate USD -11.4 million. Q3 revenue USD 98 thousand vs. IBES estimate USD 216 thousand","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX4F534C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2582373954","title":"BioXcel Therapeutics Q3 Basic EPS USD -2.18 VS. Ibes Estimate USD -1.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373954?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX4F534C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2582373670","title":"BioXcel Therapeutics Q3 Revenue USD 98 Thousand VS. Ibes Estimate USD 216 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373670","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373670?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX4F534C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2582887040","title":"BioXcel Therapeutics Reports Phase 3 Study Results on BXCL501 for Agitation in Bipolar Disorder and Schizophrenia at Home","url":"https://stock-news.laohu8.com/highlight/detail?id=2582887040","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582887040?lang=en_us&edition=fundamental","pubTime":"2025-11-10 23:02","pubTimestamp":1762786961,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. published a document detailing results from a Phase 3 study evaluating BXCL501  for the treatment of agitation associated with bipolar disorder or schizophrenia in the home setting. The document reports on the safety and efficacy of BXCL501, noting that the treatment was safe and well tolerated over a 12-week period, with consistent reduction in agitation symptoms and no increase in adverse events with repeat dosing. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL1LbWVt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2580441189","title":"BioXcel Therapeutics Inc. Announces Date for 2025 Annual Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2580441189","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580441189?lang=en_us&edition=fundamental","pubTime":"2025-11-01 05:16","pubTimestamp":1761945382,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. will hold its annual meeting of stockholders on December 12, 2025. The meeting will be conducted virtually via live webcast.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioXcel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL94BhKh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2579148327","title":"BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2579148327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579148327?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:20","pubTimestamp":1761823213,"startTime":"0","endTime":"0","summary":"BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC FilingOct 30  - BioXcel Therapeutics Inc BTAI.O:BIOXCEL THERAPEUTICS INC - UPDATES ON SNDA SUBMISSION FOR IGALMI LABEL EXPANSION - SEC FILINGBIOXCEL THERAPEUTICS INC - EXPECTS SNDA SUBMISSION COMPLETION EARLY Q1 2026 - SEC FILINGSource text: [ID:n0001104659-25-104009]Further company coverage: BTAI.O  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WB231:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2579292110","title":"BioXcel Therapeutics Inc - Updates on Snda Submission for Igalmi Label Expansion - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2579292110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579292110?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:18","pubTimestamp":1761823139,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WB231:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BTAI"],"gpt_icon":0},{"id":"2579832148","title":"BioXcel Therapeutics Reports Positive Phase 3 Results for IGALMI At-Home Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2579832148","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579832148?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:16","pubTimestamp":1761822984,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. announced the completion of the SERENITY At-Home Pivotal Phase 3 Safety Trial for IGALMI, which is approved for the acute treatment of agitation associated with bipolar I or II disorder or schizophrenia in medically supervised settings. The company reported positive topline safety and exploratory efficacy data from the trial in August 2025. Additionally, in October 2025, BioXcel completed a correlation study that supported the exploratory efficacy outcomes of the SERENITY At-Home trial and announced positive results. The data from these studies will be included in a planned Supplemental New Drug Application  to the FDA, seeking to expand the label for IGALMI to include at-home use. The company expects to complete the sNDA submission in the first quarter of 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL5TvvRG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0},{"id":"2575574156","title":"H.C. Wainwright Keeps Their Buy Rating on Bioxcel Therapeutics (BTAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2575574156","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575574156?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:55","pubTimestamp":1760619316,"startTime":"0","endTime":"0","summary":"In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Bioxcel Therapeutics, with a price target of $10.00. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-bioxcel-therapeutics-btai-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-bioxcel-therapeutics-btai-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BTAI"],"gpt_icon":0},{"id":"2575291481","title":"BioXcel Therapeutics Announces Positive Correlation Study Results Supporting At-Home Use of BXCL501 for Acute Agitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2575291481","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575291481?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:02","pubTimestamp":1760439758,"startTime":"0","endTime":"0","summary":"BioXcel Therapeutics Inc. has announced positive results from a correlation study related to exploratory efficacy outcomes from the SERENITY At Home trial. The study evaluated the correlation between the Positive and Negative Syndrome Scale - Excited Component , administered by a clinician, and the modified Clinical Global Impression-Severity  scale, which can be rated by patients or caregivers. The prospective, open-label, in-clinic trial included 33 patients and demonstrated a strong correlation between clinician and patient/caregiver assessments, with correlation coefficients of ρ=0.89  and ρ=0.88 , both with p<0.0001. No serious adverse events were reported and the safety profile was consistent with the current IGALMI label. The results, along with data from the SERENITY At Home trial, will be included in a supplemental New Drug Application  submission planned for the first quarter of 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL81R1Vl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTAI","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}